Advertisement
Axsome Therapeutics, Inc.

Axsome Therapeutics, Inc. (AXSM) Stock Overview

Explore Axsome Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

AXSM●NASDAQ
HealthcareBiotechnology
$231.48
$2.01(0.86%)
U.S. Market opens in 16h 8m
Advertisement

Axsome Therapeutics, Inc. (AXSM)

Meyka AI Score

Z

Key Financials

Market Cap11.9B
P/E Ratio-62.99
EPS (TTM)$-3.73
ROE-2.60%
Fundamental Analysis

AI Price Forecasts

1 Month$142.27
3 Months$175.41
1 Year Target$170.02

AXSM Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Axsome Therapeutics, Inc. (AXSM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 62.30, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $170.02.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -62.99 and a market capitalization of 11.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.86%
5-Day Change
-0.02%
1-Month Change
3.48%
3-Month Change
41.08%
6-Month Change
56.36%
Year-to-Date (YTD) Change
26.74%
1-Year Change
114.06%
3-Year Change
209.38%
5-Year Change
277.50%
All-Time (Max) Change
2548.51%

Contact Information

https://www.axsome.com
212 332 3241
22 Cortlandt Street, New York City, NY, 10007

Company Facts

712 Employees
IPO DateNov 19, 2015
CountryUS
Actively Trading

Frequently Asked Questions